Kool Koala grew from one to many locations specializing in children’s dental care by focusing on a comforting patient ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in ...

Urologists, including those who specialize in pediatrics, remain in high demand across the US. Several factors contribute to ...

MannKind’s Afrezza wins FDA approval for pediatric use—unlocking growth and a $300–500M opportunity. Read here for more on ...

Results presented here showed minimal changes in coronal plane alignment after physeal-sparing and transphyseal ACL ...

Officials with the University of Mississippi Medical Center (UMMC) announced Priscilla and David O’Donnell have made a $4 ...

Dr. Ashley Margol, Director, Neuro-Oncology Program and Co-Director of the Brain Tumor Program at CHLA, is joined by ...

A new study leverages a modified pyrvinium hybrid to block GLI and WNT pathways, halting pediatric medulloblastoma relapse.

Pediatric Neurological Disorders require early diagnosis and intervention for better outcomes. Dr. Mohana Rao Patibandla ...

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Ironwood Pharmaceuticals, Inc.

Lawmakers from Missouri and Kansas are demanding answers as to why funding cuts have been made to pediatric brain cancer research.

Capital Partners ("o15"), through its o15 Emerging America Credit Opportunities ("EACO") fund and its affiliates, is pleased ...